Seres Therapeutics Inc buy Quitte
Start price
17.08.16
/
50%
€10.03
Target price
17.02.17
€12.80
Performance (%)
-10.50%
End price
17.02.17
€8.97
Summary
This prediction ended on 17.02.17 with a price of €8.97. The prediction for Seres Therapeutics Inc disappointed with a performance of -10.50%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Seres Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % | 60,35 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % | 85,81 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % | 64,40 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % | 59,42 % |
Comments by Quitte for this prediction
In the thread Seres Therapeutics Inc diskutieren
hübsches Cash-Polster
und eine üble Abstrafung lassen mich hier zuversichtlich sein
(Laufzeit überschritten)

